NCT00829530View on ClinicalTrials.gov

Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Healthy
Interventions
DRUG

Ramipril 10 mg capsule

1 x 10 mg

DRUG

Altace® 10 mg capsule

1 x 10 mg

Trial Locations (2)

H2X 2H9

Anapharm Inc., Montreal

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00829530 - Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions | Biotech Hunter | Biotech Hunter